510(k) K200898
K200898 is an FDA 510(k) premarket notification submitted by Medicon Hellas S.A for the device "Medicon Hellas Albumin, Medicon Hellas Calcium, Medicon Hellas Creatinine, Medicon Hellas Urea Nitrogen, Medicon Hellas Glucose, Medicon Hellas Total Bilirubin, Medicon Hellas Direct Bilirubin". The FDA issued a decision of Substantially Equivalent on September 21, 2021. The device falls under product code CIX (Bromcresol Green Dye-Binding, Albumin), a Class II device regulated under 21 CFR 862.1035. Medicon Hellas S.A has at least 2 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- September 21, 2021
- Date Received
- April 3, 2020
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Bromcresol Green Dye-Binding, Albumin
- Device Class
- Class II
- Regulation Number
- 862.1035
- Review Panel
- CH
- Submission Type